Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence and Longevity of SARS-CoV-2 Antibodies in Healthcare Workers: A Single Center Study

Michael Brant-Zawadzki, Deborah Fridman, Philip A. Robinson, Matthew Zahn, Clayton Chau, Randy German, Marcus Breit, Elmira Burke, Jason R. Bock, Junko Hara
doi: https://doi.org/10.1101/2020.10.09.20210229
Michael Brant-Zawadzki
1Hoag Center for Research and Education, Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Fridman
1Hoag Center for Research and Education, Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip A. Robinson
2Infection Prevention, Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Zahn
3Orange County Health Care Agency, Santa Ana, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clayton Chau
3Orange County Health Care Agency, Santa Ana, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randy German
4Laboratory Administrative Services, Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Breit
5Hoag Family Cancer Institute, Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elmira Burke
6Quality Management, Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason R. Bock
7Medical Care Corporation, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junko Hara
1Hoag Center for Research and Education, Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
7Medical Care Corporation, Newport Beach, California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: junko.hara@hoag.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Understanding SARS-CoV-2 antibody prevalence as a marker of prior infection in a spectrum of healthcare workers (HCWs) may guide risk stratification and enactment of better health policies and procedures.

The present study reported on cross-sectional study to determine the prevalence and longevity of SARS-CoV-2 antibodies in HCWs at a regional hospital system in Orange County, California, between May and August, 2020.

Data from HCWs (n=3,458) were included in the analysis. Data from first responders (n=226) were also analyzed for comparison. A blood sample was collected at study enrollment and 8-week follow-up. Information on job duties, location, COVID-19 symptoms, polymerase chain reaction test history, travel since January 2020, and household contacts with COVID-19 was collected. Comparisons to estimated community prevalence were also evaluated.

Observed antibody prevalence was 0.93% and 2.58% at initial and 8-week follow-up, respectively, for HCWs, and 5.31% and 4.35% for first responders. For HCWs, significant differences (p < .05) between negative vs. positive at initial assessment were found for age, race, fever, and loss of smell, and at 8-week follow-up for age, race, and all symptoms. Antibody positivity persisted at least 8 weeks in this cohort. Among 75 HCWs with self-reported prior PCR-confirmed COVID-19, 35 (46.7%) were antibody negative. Significant differences between negative vs. positive were observed in age and frequency of symptoms.

This study found considerably lower SARS-CoV-2 antibody prevalence among HCWs compared with prior published studies. This may be explained by better safety measures in the workplace, heightened awareness inside and outside of the workplace, possibly lower susceptibility due to innate immunity and other biological heterogeneity, and low COVID-19 prevalence in the community itself. HCWs with initial positive results had persistent positive serologies at 8 weeks. Further research is warranted to investigate factors influencing such lower prevalence in our HCWs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study is supported by Orange County Healthcare Agency and Hoag Hospital Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional review board (IRB) approval was obtained for this study from Providence St. Joseph Health IRB (IRB# 2020000337).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be made available upon acceptance of the manuscript at the current submission.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 11, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence and Longevity of SARS-CoV-2 Antibodies in Healthcare Workers: A Single Center Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence and Longevity of SARS-CoV-2 Antibodies in Healthcare Workers: A Single Center Study
Michael Brant-Zawadzki, Deborah Fridman, Philip A. Robinson, Matthew Zahn, Clayton Chau, Randy German, Marcus Breit, Elmira Burke, Jason R. Bock, Junko Hara
medRxiv 2020.10.09.20210229; doi: https://doi.org/10.1101/2020.10.09.20210229
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Prevalence and Longevity of SARS-CoV-2 Antibodies in Healthcare Workers: A Single Center Study
Michael Brant-Zawadzki, Deborah Fridman, Philip A. Robinson, Matthew Zahn, Clayton Chau, Randy German, Marcus Breit, Elmira Burke, Jason R. Bock, Junko Hara
medRxiv 2020.10.09.20210229; doi: https://doi.org/10.1101/2020.10.09.20210229

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (196)
  • Anesthesia (54)
  • Cardiovascular Medicine (491)
  • Dentistry and Oral Medicine (90)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5693)
  • Forensic Medicine (3)
  • Gastroenterology (217)
  • Genetic and Genomic Medicine (869)
  • Geriatric Medicine (88)
  • Health Economics (232)
  • Health Informatics (762)
  • Health Policy (393)
  • Health Systems and Quality Improvement (254)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6491)
  • Intensive Care and Critical Care Medicine (391)
  • Medical Education (118)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (850)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (163)
  • Occupational and Environmental Health (263)
  • Oncology (515)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (970)
  • Public and Global Health (2235)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (81)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)